Skip to search formSkip to main contentSkip to account menu

Bupropion

Known as: Amfebutamone, (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone, BUP 
An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown. This agent does not… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
BACKGROUND After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known… 
Highly Cited
2006
Highly Cited
2006
ContextVarenicline, a partial agonist at the α4β2 nicotinic acetylcholine receptor, has the potential to aid smoking cessation by… 
Highly Cited
2006
Highly Cited
2006
ContextThe α4β2 nicotinic acetylcholine receptors (nAChRs) are linked to the reinforcing effects of nicotine and maintaining… 
Highly Cited
2004
Highly Cited
2004
Highly Cited
2003
Highly Cited
2003
Evidence for benefit from nicotine replacement therapy in hospital patients is inconclusive, although the results of a trial… 
Highly Cited
2000
Highly Cited
2000
Neuronal nicotinic receptors are ligand-gated ion channels of the central and peripheral central nervous system that regulate… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… 
Highly Cited
1997
Highly Cited
1997
Background and Methods Trials of antidepressant medications for smoking cessation have had mixed results. We conducted a double… 
Review
1995
Review
1995
BACKGROUND The mechanism of action of the novel antidepressant bupropion remains unclear after many years of study. A review of…